Literature DB >> 2370101

Isotypic profiles of antibody responses to Toxoplasma gondii infection in rats and mice: kinetic study and characterization of target antigens of immunoglobulin A antibodies.

I Godard1, F Darcy, D Deslee, J P Dessaint, A Capron.   

Abstract

The antibody responses to Toxoplasma gondii were investigated in rat and mouse experimental models. The immunoglobulin A (IgA) antibody response was of particular interest because acquisition of Toxoplasma gondii is usually by the oral route. The rat model was used because the natural resistance of rats to the parasite is similar to the natural resistance exhibited by adult humans. There was an early and simultaneous rise in IgA and IgM antibody responses. The IgA antibody response was maximal around day 40. IgA antibodies from Fischer rats were mainly directed against soluble and membrane antigens of 28.5, 29, 30, 35, and 38 kilodaltons (kDa). In mice, however, a major antigen of 29 kDa was recognized by IgA antibodies. Moreover, in orally infected rats, an intense IgE antibody response against the major surface antigen, P30, was observed. An IgA antibody response was also observed in rats and mice immunized with Toxoplasma excreted-secreted antigens, even without adjuvant. This response was mainly directed against 28.5- and 34-kDa antigens in rats. Serum IgA from infected rats tested against the excreted-secreted antigens bound to 28.5- 34-, and 39-kDa antigens, whereas sera from infected mice recognized only the 34-kDa antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370101      PMCID: PMC258839          DOI: 10.1128/iai.58.8.2446-2451.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

Review 2.  Vaccination against parasitic diseases: some alternative concepts for the definition of protective antigens.

Authors:  A Capron; J P Dessaint
Journal:  Ann Inst Pasteur Immunol       Date:  1988 Jan-Feb

3.  Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii.

Authors:  F Darcy; D Deslee; F Santoro; H Charif; C Auriault; A Decoster; V Duquesne; A Capron
Journal:  Parasite Immunol       Date:  1988-09       Impact factor: 2.280

4.  Modification of host cell phagosomes by Toxoplasma gondii involves redistribution of surface proteins and secretion of a 32 kDa protein.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Eur J Cell Biol       Date:  1988-10       Impact factor: 4.492

5.  Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; J van der Veen
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

6.  Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection.

Authors:  J Huskinson; P N Stepick-Biek; F G Araujo; P Thulliez; Y Suzuki; J S Remington
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Protective effects of anti-antiidiotypic IgE antibodies obtained from an IgE monoclonal antibody specific for a 26-kilodalton Schistosoma mansoni antigen.

Authors:  F Velge-Roussel; C Verwaerde; J M Grzych; A Auriault; A Capron
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

8.  Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.

Authors:  A Decoster; F Darcy; A Capron
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Regulation of immunoglobulin E production in mice immunized with an extract of Toxoplasma gondii.

Authors:  N Watanabe; A Kobayashi
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Protective role of IgE in immunocompromised rat toxoplasmosis.

Authors:  P R Ridel; C Auriault; F Darcy; R J Pierce; P Leite; F Santoro; J L Neyrinck; J P Kusnierz; A Capron
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

View more
  11 in total

1.  Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells.

Authors:  Véronique Sergent; Bastien Cautain; Jamal Khalife; Didier Deslée; Patrick Bastien; Anne Dao; Jean-François Dubremetz; Gilbert J Fournié; Abdelhadi Saoudi; Marie-France Cesbron-Delauw
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Kinetics study and characterisation of target excreted/secreted antigens of immunoglobulin G, M, A and E antibodies from mice infected with different strains of Toxoplasma gondii.

Authors:  P Cazabonne; M H Bessieres; J P Seguela
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Kinetics and time dependence of the differential agglutination of acetone [AC]- and formalin [HS]-fixed Toxoplasma tachyzoites by serum of mice with experimental toxoplasmosis.

Authors:  Nehad Mahmoud Ali; Khaled Sayed Mohamed Habib
Journal:  J Parasit Dis       Date:  2012-01-20

4.  Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.

Authors:  Yee Ling Lau; Girija Thiruvengadam; Wei Wei Lee; Mun Yik Fong
Journal:  Parasitol Res       Date:  2011-04-01       Impact factor: 2.289

5.  Identification of T cell epitopes within a 23-kD antigen (P24) of Toxoplasma gondii.

Authors:  V Duquesne; C Auriault; H Gras-Masse; C Boutillon; F Darcy; M F Cesbron-Delauw; A Tartar; A Capron
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

6.  Monoclonal rat antibodies directed against Toxoplasma gondii suitable for studying tachyzoite-bradyzoite interconversion in vivo.

Authors:  U Gross; H Bormuth; C Gaissmaier; C Dittrich; V Krenn; W Bohne; D J Ferguson
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

7.  Rat model of congenital toxoplasmosis: rate of transmission of three Toxoplasma gondii strains to fetuses and protective effect of a chronic infection.

Authors:  L Zenner; F Darcy; M F Cesbron-Delauw; A Capron
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  IgA antibody response during acquired and congenital toxoplasmosis.

Authors:  M H Bessières; C Roques; A Berrebi; V Barre; M Cazaux; J P Séguéla
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

9.  A highly conserved Toxo1 haplotype directs resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and host macrophage.

Authors:  Pierre Cavailles; Pierre Flori; Olivier Papapietro; Cordelia Bisanz; Dominique Lagrange; Ludovic Pilloux; Céline Massera; Sara Cristinelli; Delphine Jublot; Olivier Bastien; Corinne Loeuillet; Delphine Aldebert; Bastien Touquet; Gilbert J Fournié; Marie France Cesbron-Delauw
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

10.  DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice.

Authors:  Ibrahim A Hassan; Shuai Wang; LiXin Xu; RuoFeng Yan; XiaoKai Song; Xiangrui Li
Journal:  Parasit Vectors       Date:  2014-09-08       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.